| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 56857 |
| 1 | ADALIMUMAB | 47452 |
| 2 | DUPILUMAB | 40378 |
| 3 | TIRZEPATIDE | 14616 |
| 4 | METHOTREXATE SODIUM | 14338 |
| 5 | METHOTREXATE | 14173 |
| 6 | EVOLOCUMAB | 11254 |
| 7 | DULAGLUTIDE | 10019 |
| 8 | GALCANEZUMAB-GNLM | 7789 |
| 9 | PREDNISONE | 7474 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SOMATROGON-GHLA | 805 | 0.6455 |
| 1 | GALCANEZUMAB-GNLM | 7789 | 0.2410 |
| 2 | ERGOCALCIFEROL | 7009 | 0.2357 |
| 3 | GLATIRAMER ACETATE INJECTION | 719 | 0.1527 |
| 4 | ASFOTASE ALFA | 1351 | 0.1309 |
| 5 | CABOTEGRAVIR | 943 | 0.1150 |
| 6 | FREMANEZUMAB-VFRM | 1358 | 0.1147 |
| 7 | DULAGLUTIDE | 10019 | 0.1121 |
| 8 | IXEKIZUMAB | 3931 | 0.1054 |
| 9 | NALTREXONE | 3180 | 0.1024 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 61024 |
| 1 | Interleukin-4 Receptor alpha Antagonist [EPC] | 40378 |
| 2 | GLP-1 Receptor Agonist [EPC] | 28511 |
| 3 | Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] | 14616 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 13879 |
| 5 | PCSK9 Inhibitor [EPC] | 12599 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 12249 |
| 7 | Corticosteroid [EPC] | 11934 |
| 8 | Insulin Analog [EPC] | 10240 |
| 9 | Vitamin C [EPC] | 8919 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 944 | 1.3721 |
| 1 | PCSK9 Inhibitor [EPC] | 12599 | 0.4892 |
| 2 | Adrenocorticotropic Hormone [EPC] | 315 | 0.3520 |
| 3 | Provitamin D2 Compound [EPC] | 7009 | 0.2355 |
| 4 | Endoglycosidase [EPC] | 397 | 0.2142 |
| 5 | Interleukin-17A Antagonist [EPC] | 7477 | 0.2005 |
| 6 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1351 | 0.1309 |
| 7 | Interleukin-13 Antagonist [EPC] | 691 | 0.1030 |
| 8 | Guanylate Cyclase-C Agonist [EPC] | 188 | 0.0906 |
| 9 | Recombinant Human Growth Hormone [EPC] | 1940 | 0.0882 |